They also suppress appetite and heighten feelings of fullness by sending signals to the brain that regulate hunger and satiety, aiding in weight loss
35 Significant advances in pharmacological treatment have primarily focused on HFrEF, the current therapy for which is built on four key pillars: angiotensin receptorneprilysin inhibitor (ARNI) or, alternatively, ACE inhibitors or angiotensin receptor blockers
2 In a Cleveland Clinic article, Dr
Metabolism 65(8):10621079 Moreira GV, Azevedo FF, Ribeiro LM, Santos A, Guadagnini D, Gama P, Liberti EA, Saad M, Carvalho C (2018) Liraglutide modulates gut microbiota and reduces NAFLD in obese mice
In the hypothalamic arcuate nucleus it stimulates POMC neurons and inhibits AgRP/NPY signaling to reduce appetite, and it delays gastric emptying to prolong satiety
Having said that, I would say a good deal of primary care clinicians are not aware enough about these medications